The drugmaker, which focuses on developing neurological therapies, appointed Mike McDonnell as its new CFO, and he will take over Aug. 15. Mr. Capello will hold the position until then and will stay with Biogen for one month afterward to help ease the transition of leadership.
Mr. McDonnell currently serves as the executive vice president and CFO of IQVIA, a Durham, N.C.-based health technology company. In his new role at Biogen, he will manage the drugmaker’s global finance affairs, information technology, shared services center and investor relations groups.
More articles on pharmacy:
Pfizer, BioNTech sign $1.95B vaccine distribution deal with the US
‘Enough is enough’: APhA CEO calls for pharmacy reimbursement overhaul
10 drugmakers expected to make the most money in the next 5 years
